ARTICLE | Clinical News
Neuprex rBPI-21 bactericidal/permeability increasing protein: Began a Phase II efficacy trial in 400 patients who have received at least two units of blood with
May 30, 1995 7:00 AM UTC
The study will enroll patients whose onset of trauma is known and who don't have other serious medical complications. ...